The University of Hyderabad (UoH), an Institution of Eminence, and MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, have signed a Memorandum of Understanding (MoU) to collaborate on cutting-edge research and development in precision oncology.
The partnership aims to leverage the strengths of both institutions to develop innovative solutions for cancer diagnosis and treatment. UoH will contribute its expertise in advanced research and technology, while MNJ Institute of Oncology will provide clinical insights, patient data, and access to its research facilities. The collaboration will focus on personalised medicine, the development of new technologies, and the improvement of treatment outcomes for cancer patients.
The MoU enables joint research projects, knowledge sharing, and capacity building initiatives between the two institutions. It also paves the way for the development of intellectual property and potential commercialisation of research outcomes.
“This collaboration marks a significant step towards translating research into tangible outcomes that can impact cancer care in India and beyond,’’ B.J. Rao, Vice-Chancellor, UoH, said in a release.
GJ Benjamin, Director, MNJ Institute of Oncology, said: “We look forward to working together to develop innovative solutions for cancer treatment and improve patient outcomes.”
The MoU is valid for five years and can be extended or terminated by mutual consent. The partnership is expected to yield significant outcomes in cancer research and treatment, advancing healthcare in India.
Published on February 16, 2026